{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T14:50:43Z","timestamp":1794840643924,"version":"4.9.1"},"reference-count":95,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>Placenta accreta spectrum (PAS) disorder, characterized by failure of the abnormally adherent placenta to detach from the uterus after delivery, is a leading cause of severe maternal morbidity. Despite its relatively low incidence, disproportional contributions to perinatal hemorrhage, massive transfusion, and emergency hysterectomy underscore the critical need for development of evidence-based surgical management strategies for PAS. There is clear benefit to preoperative management of anemia, as well as preparation for intraoperative resuscitation with blood products and cell salvage. Several tenets of normal cesarean delivery should be maintained in PAS delivery such as the use of neuraxial anesthesia until delivery, prophylactic antibiotics, mechanical thromboprophylaxis intraoperatively, and administration of tranexamic acid if excessive bleeding occurs. Elements of surgical management distinctive to PAS and accepted as best practice include the following: planning delivery at centers with experienced teams when PAS is suspected antenatally, global intraoperative uterine and pelvic survey on entry into the abdominal cavity to assess for anatomic distortion or abnormal vascularity, selection of hysterotomy site for delivery well away from the placental margin, and direct visual assessment of the placental relationship with the myometrium after neonatal delivery and during the start of uterine involution. Other morbidity-reducing strategies such as routine cystoscopy with or without ureteral stent placement, unconventional transverse abdominal entry, hysterotomy extension with surgical staplers, and endovascular hemorrhage reduction tactics involving aortic or iliac balloon occlusion and multivessel arterial embolization remain experimental and require further research.<\/jats:p>","DOI":"10.1097\/aog.0000000000005920","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T21:00:40Z","timestamp":1745528440000},"page":"595-610","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Evidence-Based Perioperative Management of Placenta Accreta Spectrum Disorder"],"prefix":"10.1097","volume":"145","author":[{"given":"Jennifer B.","family":"Gilner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"R1-20250515","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijgo.12407","article-title":"FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology","volume":"140","author":"Jauniaux","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"R2-20250515","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijgo.12761","article-title":"FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders","volume":"146","author":"Jauniaux","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"R3-20250515","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1038\/s41598-024-55531-6","article-title":"Anaemia and red blood cell transfusion in women with placenta accreta spectrum: an analysis of 38,060 cases","volume":"14","author":"Kloka","year":"2024","journal-title":"Sci Rep"},{"key":"R4-20250515","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12884-024-06279-4","article-title":"Obstetric blood transfusion in placenta previa patients with prenatal anemia: a retrospective study","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"R5-20250515","doi-asserted-by":"crossref","first-page":"10760296231214536","DOI":"10.1177\/10760296231214536","article-title":"Prepartum anemia and risk of postpartum hemorrhage: a meta-analysis and brief review","volume":"29","author":"Glonnegger","year":"2023","journal-title":"Clin Appl Thromb Hemost"},{"key":"R6-20250515","doi-asserted-by":"crossref","first-page":"e940443","DOI":"10.12659\/MSM.940443","article-title":"Impact of maternal preoperative hemoglobin levels on intraoperative hemorrhage risk in placenta accrete spectrum disorders: a retrospective cross-sectional study","volume":"29","author":"Zhang","year":"2023","journal-title":"Med Sci Monit"},{"key":"R7-20250515","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/AOG.0000000000002442","article-title":"Outcomes of planned compared with urgent deliveries using a multidisciplinary team approach for morbidly adherent placenta","volume":"131","author":"Shamshirsaz","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R8-20250515","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jogc.2018.12.004","article-title":"No. 383\u2013screening, diagnosis, and management of placenta accreta spectrum disorders","volume":"41","author":"Hobson","year":"2019","journal-title":"J Obstet Gynaecol Can"},{"key":"R9-20250515","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ajog.2019.02.054","article-title":"Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta","volume":"220","author":"Collins","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R10-20250515","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1097\/AOG.0000000000002983","article-title":"Placenta accreta spectrum. Obstetric Care Consensus No. 7. American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R11-20250515","first-page":"e1","article-title":"Placenta praevia and placenta accreta: diagnosis and management: Green-Top Guideline No. 27a","volume":"126","author":"Jauniaux","year":"2019","journal-title":"BJOG"},{"key":"R12-20250515","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/AOG.0b013e3181f3588d","article-title":"Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta","volume":"116","author":"Robinson","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R13-20250515","doi-asserted-by":"crossref","first-page":"101432","DOI":"10.1016\/j.ajogmf.2024.101432","article-title":"Emergency delivery in pregnancies at high probability of placenta accreta spectrum on prenatal imaging: a systematic review and meta-analysis","volume":"6","author":"Lucidi","year":"2024","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R14-20250515","doi-asserted-by":"crossref","first-page":"100718","DOI":"10.1016\/j.ajogmf.2022.100718","article-title":"Timing of delivery for placenta accreta spectrum: the Pan-American Society for the Placenta Accreta Spectrum Experience","volume":"4","author":"Salmanian","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R15-20250515","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/aogs.13140","article-title":"Patient selection for later delivery timing with suspected previa-accreta","volume":"96","author":"Perlman","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R16-20250515","doi-asserted-by":"crossref","first-page":"10692","DOI":"10.1080\/14767058.2022.2157716","article-title":"Impact of placenta accreta spectrum (PAS) pathology on neonatal respiratory outcomes in cesarean hysterectomies","volume":"35","author":"Munoz","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R17-20250515","doi-asserted-by":"crossref","first-page":"B36","DOI":"10.1016\/j.ajog.2021.07.023","article-title":"Society for Maternal-Fetal Medicine Consult Series #58: use of antenatal corticosteroids for individuals at risk for late preterm delivery: replaces SMFM statement #4, implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016","volume":"225","author":"Reddy","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R18-20250515","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/AOG.0000000000002237","article-title":"Antenatal corticosteroid therapy for fetal maturation. Committee Opinion No. 713. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R19-20250515","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","article-title":"Antenatal betamethasone for women at risk for late preterm delivery","volume":"374","author":"Gyamfi-Bannerman","year":"2016","journal-title":"N Engl J Med"},{"key":"R20-20250515","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1055\/s-0040-1714676","article-title":"Planned versus unplanned delivery for placenta accreta spectrum","volume":"39","author":"Fishel Bartal","year":"2022","journal-title":"Am J Perinatol"},{"key":"R21-20250515","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2017.10.019","article-title":"Society for Maternal-Fetal Medicine (SMFM) Consult Series #44: management of bleeding in the late preterm period","volume":"218","author":"Gyamfi-Bannerman","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20250515","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/1471-0528.16993","article-title":"Hospital surgical volume-outcome relationship in caesarean hysterectomy for placenta accreta spectrum","volume":"129","author":"Matsuo","year":"2022","journal-title":"BJOG"},{"key":"R23-20250515","doi-asserted-by":"crossref","first-page":"612.e1","DOI":"10.1016\/j.ajog.2017.02.016","article-title":"Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time","volume":"216","author":"Shamshirsaz","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R24-20250515","doi-asserted-by":"crossref","first-page":"218.e1","DOI":"10.1016\/j.ajog.2014.08.019","article-title":"Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach","volume":"212","author":"Shamshirsaz","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R25-20250515","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12630-022-02385-z","article-title":"Perioperative outcomes of placenta accreta spectrum cesarean delivery in a hybrid vs labour and delivery operating room","volume":"70","author":"Ronel","year":"2023","journal-title":"Can J Anaesth"},{"key":"R26-20250515","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2023.09.001","article-title":"Society for Maternal-Fetal Medicine special statement: emergency checklist, planning worksheet, and system preparedness bundle for placenta accreta spectrum","volume":"230","author":"Einerson","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"R27-20250515","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ijgo.15096","article-title":"Anesthesia and postpartum pain management for placenta accreta spectrum: the healthcare provider perspective","volume":"164","author":"Bartels","year":"2024","journal-title":"Int J Gynaecol Obstet"},{"key":"R28-20250515","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1055\/s-0043-1761637","article-title":"Anesthesia considerations for placenta accreta spectrum","volume":"40","author":"Warrick","year":"2023","journal-title":"Am J Perinatol"},{"key":"R29-20250515","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00540-023-03287-0","article-title":"Perinatal outcomes comparison between neuraxial and general anesthesia in pregnant women with placenta accreta spectrum: a multicenter retrospective study","volume":"38","author":"Liu","year":"2024","journal-title":"J Anesth"},{"key":"R30-20250515","doi-asserted-by":"crossref","first-page":"8640","DOI":"10.1080\/14767058.2021.1990885","article-title":"Neuraxial to general anesthesia conversion has equitable intraoperative and improved post-operative outcomes compared to general anesthesia in cesarean hysterectomy for placenta accreta spectrum (PAS)","volume":"35","author":"Munoz","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R31-20250515","doi-asserted-by":"crossref","first-page":"110573","DOI":"10.1016\/j.jclinane.2021.110573","article-title":"Anesthetic management of placenta accreta spectrum at an academic center and a comparison of the combined spinal epidural with the double catheter technique: a retrospective study","volume":"77","author":"Herbert","year":"2022","journal-title":"J Clin Anesth"},{"key":"R32-20250515","doi-asserted-by":"crossref","first-page":"103220","DOI":"10.1016\/j.ijoa.2021.103220","article-title":"Neuraxial anesthesia and postoperative opioid administration for cesarean delivery in patients with placenta accreta spectrum disorder: a retrospective cohort study","volume":"49","author":"Panjeton","year":"2022","journal-title":"Int J Obstet Anesth"},{"key":"R33-20250515","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1515\/jpm-2022-0062","article-title":"Effect of anesthesia selection on neonatal outcomes in cesarean hysterectomies for placenta accreta spectrum (PAS)","volume":"50","author":"Munoz","year":"2022","journal-title":"J Perinat Med"},{"key":"R34-20250515","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000001245","article-title":"Prophylactic antibiotic choice and risk of surgical site infection after hysterectomy","volume":"127","author":"Uppal","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R35-20250515","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1701-2163(16)35222-7","article-title":"Antibiotic prophylaxis in gynaecologic procedures","volume":"34","author":"Van Eyk","year":"2012","journal-title":"J Obstet Gynaecol Can"},{"key":"R36-20250515","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004637.pub2","article-title":"Antibiotic prophylaxis for elective hysterectomy","author":"Ayeleke","year":"2017","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R37-20250515","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/AOG.0000000000003499","article-title":"Use of prophylactic antibiotics in labor and delivery. ACOG Practice Bulletin No. 199. American College of Obstetricians and Gynecologists","volume":"134","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R38-20250515","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1097\/AOG.0000000000002670","article-title":"Prevention of infection after gynecologic procedures. ACOG Practice Bulletin No. 195. American College of Obstetricians and Gynecologists","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R39-20250515","doi-asserted-by":"crossref","first-page":"187.e1","DOI":"10.1016\/j.ajog.2017.03.019","article-title":"Reducing surgical site infections after hysterectomy: metronidazole plus cefazolin compared with cephalosporin alone","volume":"217","author":"Till","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R40-20250515","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.semperi.2019.03.004","article-title":"Venous thromboembolism as a cause of severe maternal morbidity and mortality in the United States","volume":"43","author":"Abe","year":"2019","journal-title":"Semin Perinatol"},{"key":"R41-20250515","doi-asserted-by":"crossref","first-page":"119.e1","DOI":"10.1016\/j.ajog.2021.06.091","article-title":"Association between peripartum hysterectomy and venous thromboembolism","volume":"226","author":"Mauney","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R42-20250515","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"key":"R43-20250515","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2015.12","article-title":"Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial","volume":"313","author":"Holcomb","year":"2015","journal-title":"JAMA"},{"key":"R44-20250515","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/AOG.0000000000004976","article-title":"Red blood cell transfusion in patients with placenta accreta spectrum: a systematic review and meta-analysis","volume":"141","author":"Miller","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R45-20250515","doi-asserted-by":"crossref","first-page":"103238","DOI":"10.1016\/j.ijoa.2021.103238","article-title":"The sensitivity and specificity of rotational thromboelastometry (ROTEM) to detect coagulopathy during moderate and severe postpartum haemorrhage: a prospective observational study","volume":"49","author":"Bell","year":"2022","journal-title":"Int J Obstet Anesth"},{"key":"R46-20250515","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/anae.14628","article-title":"Four years' experience of a ROTEM\u00ae-guided algorithm for treatment of coagulopathy in obstetric haemorrhage","volume":"74","author":"McNamara","year":"2019","journal-title":"Anaesthesia"},{"key":"R47-20250515","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s12630-023-02490-7","article-title":"Use of intraoperative red cell salvage in the contemporary management of placenta accreta spectrum disorders","volume":"70","author":"Flores-Mendoza","year":"2023","journal-title":"Can J Anaesth"},{"key":"R48-20250515","doi-asserted-by":"crossref","first-page":"953334","DOI":"10.3389\/fimmu.2022.953334","article-title":"Intraoperative cell salvage as an effective intervention for postpartum hemorrhage-Evidence from a prospective randomized controlled trial","volume":"13","author":"Lei","year":"2022","journal-title":"Front Immunol"},{"key":"R49-20250515","first-page":"1","article-title":"A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the SALVO (cell SALVage in Obstetrics) trial","volume":"22","author":"Khan","year":"2018","journal-title":"Health Technol Assess"},{"key":"R50-20250515","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijoa.2019.07.003","article-title":"Efficiency of leukocyte depletion filters and micro-aggregate filters following intra-operative cell salvage during cesarean delivery","volume":"41","author":"Fujioka","year":"2020","journal-title":"Int J Obstet Anesth"},{"key":"R51-20250515","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00345-024-05239-z","article-title":"Identifying risk factors for urologic complications in placenta accreta spectrum surgical management","volume":"42","author":"Hage","year":"2024","journal-title":"World J Urol"},{"key":"R52-20250515","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/uog.26299","article-title":"Urological complications in women undergoing cesarean section for placenta accreta spectrum disorders: systematic review and meta-analysis","volume":"62","author":"Lucidi","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R53-20250515","doi-asserted-by":"crossref","first-page":"245.e1","DOI":"10.1016\/j.ajog.2021.08.010","article-title":"Urologic morbidity associated with placenta accreta spectrum surgeries: single-center experience with a multidisciplinary team","volume":"226","author":"Erfani","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R54-20250515","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1471-0528.2008.02037.x","article-title":"Optimal management strategies for placenta accreta","volume":"116","author":"Eller","year":"2009","journal-title":"BJOG"},{"key":"R55-20250515","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/AOG.0000000000004957","article-title":"Prophylactic ureteral stent placement and urinary injury during hysterectomy for placenta accreta spectrum","volume":"140","author":"Scaglione","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R56-20250515","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/14767058.2011.576720","article-title":"Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: a systematic review","volume":"25","author":"Tam","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R57-20250515","doi-asserted-by":"crossref","first-page":"101120","DOI":"10.1016\/j.ajogmf.2023.101120","article-title":"Prophylactic ureteral stent placement for the prevention of genitourinary tract injury during hysterectomy for placenta accreta spectrum: systematic review and meta-analysis","volume":"5","author":"Horgan","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R58-20250515","article-title":"Transverse versus vertical incision in the surgical management of placenta accreta spectrum","author":"Oberlin","year":"2024","journal-title":"Am J Perinatol"},{"key":"R59-20250515","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12884-020-2768-7","article-title":"Transverse versus vertical skin incision for planned cesarean hysterectomy: does it matter?","volume":"20","author":"Szlachta-McGinn","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"R60-20250515","doi-asserted-by":"crossref","first-page":"175.e1","DOI":"10.1016\/j.ajog.2021.03.014","article-title":"The modified radical peripartum cesarean hysterectomy (Soleymani-Alazzam-Collins technique): a systematic, safe procedure for the management of severe placenta accreta spectrum","volume":"225","author":"Soleymani Majd","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R61-20250515","article-title":"Choosing the abdominal incision for the surgical management of severe placenta accreta spectrum: patient satisfaction and long-term safety of the Soleymani and Collins transverse abdominal incision","author":"Soleymani","year":"2024","journal-title":"Int J Gynaecol Obstet"},{"key":"R62-20250515","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/AOG.0000000000005075","article-title":"Ultrasonography of the explanted uterus in placenta accreta spectrum: correlation with intraoperative findings and gross pathology","volume":"141","author":"Einerson","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R63-20250515","doi-asserted-by":"crossref","first-page":"1347549","DOI":"10.3389\/fsurg.2024.1347549","article-title":"Roadmap to safety: a single center study of evidence-informed approach to placenta accreta spectrum","volume":"11","author":"Levy","year":"2024","journal-title":"Front Surg"},{"key":"R64-20250515","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/jum.16090","article-title":"Intraoperative ultrasound in the management of placenta accreta spectrum: waste of time or valuable step","volume":"42","author":"Nassar","year":"2023","journal-title":"J Ultrasound Med"},{"key":"R65-20250515","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00508-016-0962-4","article-title":"Surgical management of 58 patients with placenta praevia percreta","volume":"128","author":"Camuzcuoglu","year":"2016","journal-title":"Wien Klin Wochenschr"},{"key":"R66-20250515","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/1933719113512528","article-title":"Maternal and fetal outcomes in placenta accreta after institution of team-managed care","volume":"21","author":"Al-Khan","year":"2014","journal-title":"Reprod Sci"},{"key":"R67-20250515","doi-asserted-by":"crossref","first-page":"78.e1","DOI":"10.1016\/j.ajog.2016.10.030","article-title":"Minimizing blood loss at cesarean-hysterectomy for placenta previa percreta","volume":"216","author":"Belfort","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R68-20250515","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011689.pub2","article-title":"Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis","author":"Gallos","year":"2018","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R69-20250515","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejogrb.2008.09.004","article-title":"A randomised controlled trial of oxytocin 5IU and placebo infusion versus oxytocin 5IU and 30IU infusion for the control of blood loss at elective caesarean section\u2013pilot study: ISRCTN 40302163","volume":"142","author":"Murphy","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R70-20250515","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5468\/ogs.20345","article-title":"Placenta accreta spectrum\u2013a catastrophic situation in obstetrics","volume":"64","author":"Pegu","year":"2021","journal-title":"Obstet Gynecol Sci"},{"key":"R71-20250515","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"R72-20250515","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ygyno.2024.04.004","article-title":"Cesarean hysterectomy for placenta accreta spectrum: surgeon specialty-specific assessment","volume":"186","author":"Matsuo","year":"2024","journal-title":"Gynecol Oncol"},{"key":"R73-20250515","doi-asserted-by":"crossref","first-page":"61.e1","DOI":"10.1016\/j.ajog.2023.03.028","article-title":"Implementation and outcomes of a uterine artery embolization and tranexamic acid protocol for placenta accreta spectrum","volume":"229","author":"Munoz","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"R74-20250515","article-title":"Tranexamic acid for preventing postpartum haemorrhage after caesarean section","author":"Rohwer","year":"2024","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R75-20250515","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMoa2207419","article-title":"Tranexamic acid to prevent obstetrical hemorrhage after cesarean delivery","volume":"388","author":"Pacheco","year":"2023","journal-title":"N Engl J Med"},{"key":"R76-20250515","doi-asserted-by":"crossref","first-page":"100316","DOI":"10.1016\/j.xagr.2024.100316","article-title":"Tranexamic acid to reduce blood loss in women at high risk of postpartum hemorrhage undergoing cesarean delivery-a randomized controlled trial","volume":"4","author":"Neumann","year":"2024","journal-title":"AJOG Glob Rep"},{"key":"R77-20250515","doi-asserted-by":"crossref","first-page":"17455057231225311","DOI":"10.1177\/17455057231225311","article-title":"Prophylactic tranexamic acid for reducing intraoperative blood loss during cesarean section in women at high risk of postpartum hemorrhage: a double-blind placebo randomized controlled trial","volume":"20","author":"Ortuanya","year":"2024","journal-title":"Womens Health (Lond)"},{"key":"R78-20250515","doi-asserted-by":"crossref","first-page":"101196","DOI":"10.1016\/j.ajogmf.2023.101196","article-title":"Erratum to Tranexamic acid for the prevention of blood loss after cesarean section: an updated systematic review and meta-analysis of randomized controlled trials. American Journal of Obstetrics & Gynecology MFM. Volume 5, Issue 8, August 2023, 101049","volume":"5","author":"Cheema","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R79-20250515","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/uog.14728","article-title":"Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta: a cohort study comparing outcomes before and after introduction of the triple-P procedure","volume":"46","author":"Teixidor Vi\u00f1as","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R80-20250515","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.0001-6349.2004.00517.x","article-title":"Anterior placenta percreta: surgical approach, hemostasis and uterine repair","volume":"83","author":"Palacios Jaraquemada","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R81-20250515","article-title":"Surgical morbidity following planned hysterectomy versus conservative management for placenta accreta spectrum: a systematic review and meta-analysis","author":"Futterman","year":"2024","journal-title":"Am J Perinatol"},{"key":"R82-20250515","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/s12884-024-06658-x","article-title":"Maternal outcomes of conservative management and cesarean hysterectomy for placenta accreta spectrum disorders: a systematic review and meta-analysis","volume":"24","author":"Pan","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"R83-20250515","doi-asserted-by":"crossref","first-page":"101333","DOI":"10.1016\/j.ajogmf.2024.101333","article-title":"One-step conservative surgery vs hysterectomy for placenta accreta spectrum: a feasibility randomized controlled trial","volume":"6","author":"Nieto-Calvache","year":"2024","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R84-20250515","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1080\/14767058.2017.1359535","article-title":"Planned cesarean hysterectomy versus modified form of segmental resection in patients with placenta percreta","volume":"31","author":"Kilicci","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R85-20250515","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00404-017-4447-0","article-title":"Evaluation of a modified \u201ctriple-P\u201d procedure in women with morbidly adherent placenta after previous caesarean section","volume":"296","author":"Wei","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"R86-20250515","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/AOG.0b013e3181c4f12a","article-title":"Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta","volume":"115","author":"Warshak","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R87-20250515","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/AOG.0000000000005662","article-title":"Prophylactic radiologic interventions for postpartum hemorrhage control in women with placenta accreta spectrum disorder: a systematic review and meta-analysis","volume":"144","author":"Bonsen","year":"2024","journal-title":"Obstet Gynecol"},{"key":"R88-20250515","doi-asserted-by":"crossref","first-page":"109711","DOI":"10.1016\/j.ejrad.2021.109711","article-title":"Internal iliac artery balloon occlusion in the management of placenta accreta: a systematic review and meta-analysis","volume":"139","author":"Liang","year":"2021","journal-title":"Eur J Radiol"},{"key":"R89-20250515","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.jvir.2023.07.020","article-title":"Prophylactic uterine artery embolization in placenta accreta spectrum\u2013an active intervention to reduce morbidity and promote uterine preservation","volume":"34","author":"Sebastian","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"R90-20250515","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejogrb.2020.10.056","article-title":"Retrospective review of cesarean hysterectomy outcomes utilizing uterine intravascular interventions in a large, community-based healthcare setting","volume":"255","author":"Mironov","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R91-20250515","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jvir.2014.10.013","article-title":"Feasibility and safety of prophylactic uterine artery catheterization and embolization in the management of placenta accreta","volume":"26","author":"Izbizky","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"R92-20250515","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s00330-012-2612-1","article-title":"Transcatheter arterial embolisation for the management of obstetric haemorrhage associated with placental abnormality in 40 cases","volume":"23","author":"Hwang","year":"2013","journal-title":"Eur Radiol"},{"key":"R93-20250515","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00270-021-02921-2","article-title":"Prophylactic intraoperative uterine artery embolization during cesarean section or cesarean hysterectomy in patients with abnormal placentation: a systematic review and meta-analysis","volume":"45","author":"Yang","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R94-20250515","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1055\/s-0042-1754321","article-title":"Transfusion requirements with hybrid management of placenta accreta spectrum incorporating targeted embolization and a selective use of delayed hysterectomy","volume":"29","author":"Gatta","year":"2022","journal-title":"Am J Perinatol"},{"key":"R95-20250515","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/SLA.0000000000002794","article-title":"No surgical innovation without evaluation: evolution and further development of the IDEAL framework and recommendations","volume":"269","author":"Hirst","year":"2019","journal-title":"Ann Surg"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T21:01:17Z","timestamp":1747342877000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005920","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"2025-02-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}